SITAGLIPTIN HCL

SITAGLIPTIN HCL

862156-92-1

SITAGLIPTIN HCL

862156-92-1

Therapeutic category

Antidiabetic

Standard package

Fiber drum, 50 Kg

Regulatory data

EDMF

Pharma-copoeias

in house

Production site

BENECHIM

SITAGLIPTIN HCL

Therapeutic category: Antidiabetic

Reference: 862156-92-1



Standard package​: Fiber drum, 50 Kg

Regulatory data​: EDMF

Pharma-copoeias​: in house

Production site​: BENECHIM



IUPAC name​​: 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)--[1,2,4]triazolo[4,3,-a]pyrazine hydrochloride (1:1) monohydrate.

Pharmaceutical Dose Forms:

oral tablet

SITAGLIPTIN HCL

862156-92-1

Additional information

IUPAC name

7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)–[1,2,4]triazolo[4,3,-a]pyrazine hydrochloride (1:1) monohydrate.

Pharmaceutical Dose Forms

oral tablet

Material Safety Data Sheet (MSDS)